These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 38452352
21. PHENOTYPIC CHARACTERIZATION OF PREDICTORS FOR DEVELOPMENT AND PROGRESSION OF GEOGRAPHIC ATROPHY USING OPTICAL COHERENCE TOMOGRAPHY. Fragiotta S, Dysli C, Parravano M, Sacconi R, Fantaguzzi F, Servillo A, Severo AA, Tombolini B, Costanzo E, De Geronimo D, Capuano V, Souied E, Bandello F, Querques G. Retina; 2024 Jul 01; 44(7):1232-1241. PubMed ID: 38471039 [Abstract] [Full Text] [Related]
22. SUBRETINAL DRUSENOID DEPOSIT IN AGE-RELATED MACULAR DEGENERATION: Histologic Insights Into Initiation, Progression to Atrophy, and Imaging. Chen L, Messinger JD, Zhang Y, Spaide RF, Freund KB, Curcio CA. Retina; 2020 Apr 01; 40(4):618-631. PubMed ID: 31599795 [Abstract] [Full Text] [Related]
23. Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT. Toth CA, Tai V, Pistilli M, Chiu SJ, Winter KP, Daniel E, Grunwald JE, Jaffe GJ, Martin DF, Ying GS, Farsiu S, Maguire MG, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Ophthalmol Retina; 2019 Apr 01; 3(4):316-325. PubMed ID: 31014683 [Abstract] [Full Text] [Related]
24. Persistent Hypertransmission Defects on En Face OCT Imaging as a Stand-Alone Precursor for the Future Formation of Geographic Atrophy. Shi Y, Yang J, Feuer W, Gregori G, Rosenfeld PJ. Ophthalmol Retina; 2021 Dec 01; 5(12):1214-1225. PubMed ID: 33610834 [Abstract] [Full Text] [Related]
25. Stages of Drusen-Associated Atrophy in Age-Related Macular Degeneration Visible via Histologically Validated Fundus Autofluorescence. Chen L, Messinger JD, Ferrara D, Freund KB, Curcio CA. Ophthalmol Retina; 2021 Aug 01; 5(8):730-742. PubMed ID: 33217617 [Abstract] [Full Text] [Related]
26. Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression. Thiele S, Nadal J, Pfau M, Saßmannshausen M, Fleckenstein M, Holz FG, Schmid M, Schmitz-Valckenberg S. Br J Ophthalmol; 2021 Feb 01; 105(2):239-245. PubMed ID: 32269061 [Abstract] [Full Text] [Related]
27. OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement: Classification of Atrophy Meetings Report 6. Wu Z, Pfau M, Blodi BA, Holz FG, Jaffe GJ, Liakopoulos S, Sadda SR, Staurenghi G, Bjelopera E, Brown T, Chang P, Choong J, Corradetti G, Corvi F, Domalpally A, Hurtenbach C, Nittala MG, Olson A, Pak JW, Pappe J, Saßmannshausen M, Skalak C, Thiele S, Guymer RH, Schmitz-Valckenberg S. Ophthalmol Retina; 2022 Jan 01; 6(1):4-14. PubMed ID: 33766801 [Abstract] [Full Text] [Related]
28. Local Anatomic Precursors to New-Onset Geographic Atrophy in Age-Related Macular Degeneration as Defined on OCT. Pasricha MV, Tai V, Sleiman K, Winter K, Chiu SJ, Farsiu S, Stinnett SS, Lad EM, Wong WT, Chew EY, Toth CA, Age-Related Eye Disease Study 2 Ancillary Spectral-Domain Optical Coherence Tomography Study Group. Ophthalmol Retina; 2021 May 01; 5(5):396-408. PubMed ID: 33348086 [Abstract] [Full Text] [Related]
29. Deep-learning automated quantification of longitudinal OCT scans demonstrates reduced RPE loss rate, preservation of intact macular area and predictive value of isolated photoreceptor degeneration in geographic atrophy patients receiving C3 inhibition treatment. Fu DJ, Glinton S, Lipkova V, Faes L, Liefers B, Zhang G, Pontikos N, McKeown A, Scheibler L, Patel PJ, Keane PA, Balaskas K. Br J Ophthalmol; 2024 Mar 20; 108(4):536-545. PubMed ID: 37094835 [Abstract] [Full Text] [Related]
30. OCT risk factors for 2-year foveal involvement in non-treated eyes with extrafoveal geographic atrophy and AMD. Borrelli E, Barresi C, Berni A, Viggiano P, Reibaldi M, Introini U, Bandello F. Graefes Arch Clin Exp Ophthalmol; 2024 Jul 20; 262(7):2101-2109. PubMed ID: 38326629 [Abstract] [Full Text] [Related]
31. Pegcetacoplan Treatment and Consensus Features of Geographic Atrophy Over 24 Months. Fu DJ, Bagga P, Naik G, Glinton S, Faes L, Liefers B, Lima R, Wignall G, Keane PA, Ioannidou E, Ribeiro Reis AP, McKeown A, Scheibler L, Patel PJ, Moghul I, Pontikos N, Balaskas K. JAMA Ophthalmol; 2024 Jun 01; 142(6):548-558. PubMed ID: 38722644 [Abstract] [Full Text] [Related]
32. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi G. Ophthalmology; 2018 Apr 01; 125(4):537-548. PubMed ID: 29103793 [Abstract] [Full Text] [Related]
34. Geographic Atrophy and Foveal-Sparing Changes Related to Visual Acuity in Patients With Dry Age-Related Macular Degeneration Over Time. Sayegh RG, Sacu S, Dunavölgyi R, Kroh ME, Roberts P, Mitsch C, Montuoro A, Ehrenmüller M, Schmidt-Erfurth U. Am J Ophthalmol; 2017 Jul 12; 179():118-128. PubMed ID: 28385474 [Abstract] [Full Text] [Related]
35. Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration. Folgar FA, Yuan EL, Sevilla MB, Chiu SJ, Farsiu S, Chew EY, Toth CA, Age Related Eye Disease Study 2 Ancillary Spectral-Domain Optical Coherence Tomography Study Group. Ophthalmology; 2016 Jan 12; 123(1):39-50.e1. PubMed ID: 26578448 [Abstract] [Full Text] [Related]
36. Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography. Pilotto E, Convento E, Guidolin F, Abalsamo CK, Longhin E, Parrozzani R, Midena E. JAMA Ophthalmol; 2016 Aug 01; 134(8):873-9. PubMed ID: 27253760 [Abstract] [Full Text] [Related]
37. Progression of cRORA (Complete RPE and Outer Retinal Atrophy) in Dry Age-Related Macular Degeneration Measured Using SD-OCT. Shmueli O, Yehuda R, Szeskin A, Joskowicz L, Levy J. Transl Vis Sci Technol; 2022 Jan 03; 11(1):19. PubMed ID: 35029632 [Abstract] [Full Text] [Related]
38. Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial. Daniel E, Maguire MG, Grunwald JE, Toth CA, Jaffe GJ, Martin DF, Ying GS, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. JAMA Ophthalmol; 2020 May 01; 138(5):510-518. PubMed ID: 32191267 [Abstract] [Full Text] [Related]
39. Relationship of Topographic Distribution of Geographic Atrophy to Visual Acuity in Nonexudative Age-Related Macular Degeneration. Shen LL, Sun M, Ahluwalia A, Young BK, Park MM, Toth CA, Lad EM, Del Priore LV. Ophthalmol Retina; 2021 Aug 01; 5(8):761-774. PubMed ID: 33212271 [Abstract] [Full Text] [Related]
40. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial. Brader HS, Ying GS, Martin ER, Maguire MG, Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group. Ophthalmology; 2013 Sep 01; 120(9):1871-9. PubMed ID: 23622873 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]